• In 2013, the probability of a man developing prostate
cancer (PCa) was 1 in 6, sitting on top of the charts as
the single most common area for men to develop
cancer [4].
• The most common form of treatment in New Zealand
is a funded prescription medicine called Zoladex
(Goserelin), an anti androgen medication that reduces
the production of testosterone that can fuel the growth
of the cancer.
• Suppression of testosterone production can be related
with considerable side effects including muscle atrophy
(sarcopenia/wasting), changes in weight (typically an
increase in weight from oestrogen levels dominating in
the body due to the lack of testosterone production).
• Physical activity focussing on strength training in
particular has been proposed as a favourable strategy
to reverse the side effects of Androgen deprivation
therapy (ADT), especially that of muscle wasting and
changes in body composition.